Dr Reddy’s acquires US-based oral penicillin facility
November 24th, 2010 - 4:25 pm ICT by IANSMumbai, Nov 24 (IANS) Pharmaceutical major Dr Reddy’s Laboratories Wednesday said it has entered into an agreement with GlaxoSmithKline (GSK) for acquiring its oral penicillin facility.
According to a regulatory filing by the company, GSK will transfer ownership of its oral penicillin manufacturing site in Bristol, Tennessee.
The company will also get the rights for the augmentin and amoxil brands in the American markets, while GSK will retain the existing rights for these brands outside the US.
“It allows us to enter the US penicillin-containing antibacterial market segment and serve the needs of our customers and patients through manufacturing capabilities that did not previously exist within Dr Reddy’s,” said Dr Reddy’s Laboratories’ global generics business president Abhijit Mukherjee.
The transaction is expected to close within the first half of the next calendar year. The companies did not provide any financial detail of the deal.
“The acquisition is in line with our strategy to significantly scale up our generics business in North America,” Mukherjee said.
- Dr Reddy's ties up with GlaxoSmithKline - Jun 15, 2009
- Dr.Reddy's acquires JB Chemicals business in Russia - Jul 23, 2011
- London 2012 anti-doping laboratory receives seal of approval - Apr 24, 2012
- Abbott Labs pays 3.7 bn dollars to buy into Mumbai's Piramal Healthcare - May 22, 2010
- GSK Healthcare aims at double-digit market share in oral care - May 14, 2012
- GSK to decide on rural drink after test marketing results - Oct 06, 2010
- Dr. Reddy's net rises 10 percent - Jan 20, 2009
- Ranbaxy settles issue with US health regulator - Dec 21, 2011
- Utilization Of Glaxo's Rotarix Vaccine Discontinued Provisionally - Mar 23, 2010
- Dr Reddy's net up 89 percent in 2008-09 - May 18, 2009
- GlaxoSmithKline to cut 6,000 jobs - Feb 02, 2009
- Soon, an injectable vaccine to help kick the butt - Nov 18, 2009
- GlaxoSmithKline to go public with malaria data - Jan 20, 2010
- Diabetes drug 'ups heart disease, death risk' - Feb 22, 2010
- Ranbaxy approved to make first generic version of Lipitor - Dec 01, 2011
Tags: abhijit, acquisition, american markets, amoxil, augmentin, bristol tennessee, calendar year, capabilities, dr reddy, financial detail, glaxosmithkline, gsk, market segment, north america, penicillin